Table 2. Characteristics of febrile acute de-compensated cirrhotic patients with variant/wild-type allele carriers (variant/wild-type).
Different carrier of TLR4 +896A/G polymorphism | variant allele (n = 22) | wild-type allele (n = 86) | P values |
Gender (male/female) ratio | 15/7 (68/32%) | 62/24 (72/28%) | 0.35 |
Child-Pugh class (A/B+C) (%) | 5/17(13/77%) | 19/67(22/78%) | 0.48 |
Severity of ascites (no+mild/moderate+massive)(%) | 9/13(41/59%) | 40/46(47/53%) | 0.65 |
Model of end stage liver disease (MELD) score | 17.9± 6.4 | 19.3± 4.1 | 0.33 |
Acute physiologic and chronic health (APACH) III score | 22.1 ±5.9 | 19.8± 6.5 | 0.24 |
[C-reactive protein, (CRP)] mg/dL | 4.1±1.1 | 3.9 ±1.7 | 0.41 |
[sCD14] μg/mL | 6.9±0.5* | 3.7±0.4 | 0.002 |
[IL-10] pg/mL | 17.5 ±2.2* | 9.7±1.4 | 0.01 |
[total nitric oxide (NOx)] μM | 38.5± 3.5* | 19.3 ±8.7 | 0.005 |
Previous spontaneous bacterial peritonitis (SBP) | 10(45%)** | 29(34%) | <0.001 |
Percentage of cases complicated with severe sepsis (%) | 13(59%)* | 27(31%) | 0.005 |
Different carrier of CD14 -159C/T polymorphism | variant allele (n = 33) | wild-type allele (n = 75) | |
Gender (male/female) ratio | 22/11(67/33%) | 55/20(73/27%) | 0.95 |
Child-Pugh class (A/B+C) (%) | 5/28(15/85%) | 19/56(25/75%) | 0.69 |
Ascites (no+mild/moderate+massive)(%) | 13/20(39/61%) | 36/39(48/52%) | 0.38 |
MELD score | 18.3± 2.5 | 18.4± 5.6 | 0.52 |
APACH III score | 22.3 ±5.4 | 24.1±6.3 | 0.29 |
[CRP] mg/dL | 5.7±1.9 | 4.6 ±2.1 | 0.26 |
[sCD14] μg/mL | 4.7±0.8* | 1.5±0.4 | 0.003 |
[IL-10] pg/mL | 16.8 ±1.3 | 14.3±5.7 | 0.15 |
[NOx] μM | 37.5 ±2.9* | 21.4 ±6.8 | 0.012 |
Previous SBP | 13(39%)** | 21(28%) | <0.001 |
Percentage of cases complicated with severe sepsis (%) | 14(42%)* | 23(31%) | 0.026 |
Data are mean±SD; categorical variables were expressed as case number [percentage (%) of frequency]
*P <0.01
**P <0.001 vs. TLR4 +896 A/G&CD14 -159C/T, wild-type allele carriers.